Mereo BioPharma Group (MREO)
2.37
-0.03 (-1.25%)
At close: Mar 03, 2025, 11:36 AM
Mereo BioPharma Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| Net Income | -29.47M | -36.09M | 14.24M | -166.45M | -41.12M | -37.31M | -46.95M | -33.72M |
| Depreciation & Amortization | 1.06M | 727K | 642K | 1.6M | 1.58M | 37.8K | 36.08K | 32.94K |
| Stock-Based Compensation | 4.92M | 4.77M | 4.46M | 2.12M | 1.64M | 2.19M | 3.65M | 6.49M |
| Other Working Capital | -786K | 1.13M | -1.26M | -3.55M | -6.73M | n/a | n/a | n/a |
| Other Non-Cash Items | 3.94M | -9.14M | 13.41M | 5.22M | -429K | 1.92M | 751.65K | 179.76K |
| Deferred Income Tax | n/a | n/a | -34.99M | 133.14M | 69K | 7.62M | 7.34M | 1.6M |
| Change in Working Capital | -1.59M | 1.82M | -1.84M | -3.41M | -7.67M | 2.41M | 3.02M | -1.99M |
| Operating Cash Flow | -21.13M | -38.82M | -5.24M | -28.34M | -45.93M | -23.14M | -32.15M | -27.4M |
| Capital Expenditures | -419K | -10K | -535K | -16K | -21K | -35.54K | -2.3M | -3.47K |
| Acquisitions | n/a | n/a | n/a | -354K | 10.07M | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -2.5M | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | 32.87M | n/a | n/a | n/a |
| Other Investing Acitivies | -419K | 1.51M | 114K | 1.86M | 377K | 287.09K | 1.05M | 376.08K |
| Investing Cash Flow | -419K | 1.5M | -421K | 1.5M | 43.3M | 251.56K | -3.74M | 372.61K |
| Debt Repayment | -3.19M | -1.13M | -933.95K | 30.65M | -2.9M | 577.35K | 27.03M | 4.27M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | -1.31M | -306.84K | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -444K | 349.96K | -253.73K | -23.35M | -2.5M | -2.61M | -1.7M | -3.7M |
| Financial Cash Flow | 7.97M | -784K | 77.65M | 34.74M | -5.71M | -2.07M | 33.74M | 68.36M |
| Net Cash Flow | -10.76M | -37.96M | 70.83M | 7.12M | -8.7M | -25M | -3.53M | 41.33M |
| Free Cash Flow | -21.55M | -38.83M | -5.77M | -28.36M | -45.95M | -23.17M | -34.44M | -27.4M |